Abstract:Background: Forkhead box P3+ (FOXP3 +) regulatory T cells (Tregs) are a subset of lymphocytes, critical for the maintenance of immune homeostasis. Loss-of-function mutations of the FOXP3 gene in animal models and humans results in loss of differentiation potential into Treg cells and are responsible for several immune-mediated inflammatory diseases. Strategies of increasing FOXP3 expression represent a potential approach to increase the pool of Tregs within the lymphocyte population and may be employed in therapies of diverse autoimmune conditions. In the present study, a dCas9 CRISPR-based method was systematically employed to achieve upregulation and sustained high expression of endogenous FOXP3 in HEK293 and human Jurkat T cell lines through targeting of the core promotor, three known regulatory regions of the FOXP3 gene (CNS1-3), and two additional regions selected through extensive bioinformatics analysis (Cage1 and Cage2). Results: Using an activator-domain fusion based dCas9 transcription activator, robust upregulation of FOXP3 was achieved, and an optimal combination of single guide RNAs was selected, which exerted an additive effect on FOXP3 gene upregulation. Simultaneous targeting of FOXP3 and EOS, a transcription factor known to act in concert with FOXP3 in initiating a Treg phenotype, resulted in upregulation of FOXP3 downstream genes CD25 and TNFR2. When compared to ectopic expression of FOXP3 via plasmid electroporation, upregulation of endogenous FOXP3 via the Cas9-based method resulted in prolonged expression of FOXP3 in Jurkat cells. Conclusions: Transfection of both HEK293 and Jurkat cells with dCas9-activators showed that regulatory regions downstream and upstream of FOXP3 promoter can be very potent transcription inducers in comparison to targeting the core promoter. While introduction of genes by conventional methods of gene therapy may involve a risk of insertional mutagenesis due to viral integration into the genome, transient up- or down-regulation of transcription by a CRISPR-dCas9 approach may resolve this safety concern. dCas9-based systems provide great promise in DNA footprint-free phenotype perturbations (perturbation without the risk of DNA damage) to drive development of transcription modulation-based therapies.

Cis-Regulatory Element and Transcription Factor Circuitry Required for Cell-Type Specific Expression of FOXP3

Identification and Characterization of Foxp3+ Γδ T Cells in Mouse and Human

CRISPR screen in regulatory T cells reveals modulators of Foxp3

Suppression of FOXP3 expression by the AP-1 family transcription factor BATF3 requires partnering with IRF4

Abstract 4988: FOXP3, a Critical Mediator of Regulatory T-cell Function, is Expressed in Subsets of Myeloid Cells.

FOXP3 Exon 2 Controls Treg Stability and Autoimmunity

FOXP3 exon 2 controls T reg stability and autoimmunity

Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity

Structural Aspects of the FOXP3 Regulatory Complex As an Immunopharmacological Target

The regulation of immune tolerance by FOXP3

FOXP3 Activation in Treg Cells, - Atomic Level Aspects of FOXP3 Structure and Biochemistry That Govern Function (89.4)

FOXP3 and Its Partners: Structural and Biochemical Insights into the Regulation of FOXP3 Activity

CRISPRa-mediated FOXP3 gene upregulation in mammalian cells

Transcription Factors Foxo3a and Foxo1 Couple the E3 Ligase Cbl-b to the Induction of Foxp3 Expression in Induced Regulatory T Cells

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function

CREB determines the expression of ST2 in Tregs and mediates the balance between type 1 and type 2 immune responses

Control of regulatory T‐cell differentiation and function by T‐cell receptor signalling and Foxp3 transcription factor complexes

Integrated Methods Redefine Contrasting Mechanisms Governing Foxp3 Induction and Maintenance

An integrated transcription factor framework for Treg identity and diversity

Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells.

Systematic decoding of cis gene regulation defines context-dependent control of the multi-gene costimulatory receptor locus in human T cells